2020
Molecular and clinicopathologic characterization of intravenous leiomyomatosis
Ordulu Z, Chai H, Peng G, McDonald AG, De Nictolis M, Garcia-Fernandez E, Hardisson D, Prat J, Li P, Hui P, Oliva E, Buza N. Molecular and clinicopathologic characterization of intravenous leiomyomatosis. Modern Pathology 2020, 33: 1844-1860. PMID: 32341498, PMCID: PMC7483566, DOI: 10.1038/s41379-020-0546-8.Peer-Reviewed Original ResearchConceptsIntravenous leiomyomatosisAggressive clinical behaviorClinical behaviorArray comparative genomic hybridizationCyclin D1Uterine smooth muscle tumorsSmooth muscle tumorsSmooth muscle proliferationRecurrent chromosome alterationsCommon genetic alterationsFH immunohistochemistryClinicopathologic characterizationImmunohistochemical findingsMesenchymal tumorsMuscle tumorsBenign appearanceMuscle proliferationUterine leiomyomaGroup 1Group 3Nonneoplastic tissuesIndex scoreVascular morphologyProtein expressionComparative genomic hybridization
2008
Expression of CD56 and WT1 in Ovarian Stroma and Ovarian Stromal Tumors
He H, Luthringer DJ, Hui P, Lau SK, Weiss LM, Chu PG. Expression of CD56 and WT1 in Ovarian Stroma and Ovarian Stromal Tumors. The American Journal Of Surgical Pathology 2008, 32: 884-890. PMID: 18425046, DOI: 10.1097/pas.0b013e3181609d59.Peer-Reviewed Original ResearchConceptsSpindle cell sarcomaSpindle cell tumorsOvarian stromal cellsUterine smooth muscle tumorsExpression of CD56Endometrial stromal tumorsOvarian fibromaSmooth muscle tumorsCell sarcomaCell tumorsOvarian cellular fibromasSmooth muscle actinStromal tumorsOvarian stromaProgesterone receptorNormal ovariesStromal cellsOvarian fibrothecomaOvarian leiomyomaMuscle tumorsCellular fibromaMuscle actinOvarian stromal originOvarian stromal tumorsEndometrial stromal cells